In force2024 Revised EditionCurrent version · 2024 Revised EditionSee versions on Attorney General's Chambers(opens the publisher’s site)
Medicines Act · 2024 Revised Edition · Part · Miscellaneous and Supplementary Provisions
Medicines Act · 2024 Revised Edition · Part · Miscellaneous and Supplementary Provisions
Official textFrom Attorney General's Chambers, unchanged
A licensed manufacturer, a licensed wholesaler, a licensed importer or the holder of a product licence in respect of any product shall notify the
licensed manufacturer
“licensed manufacturer” means a person to whom a manufacturer’s licence has been issued under this Act, and includes a contract manufacturer;
Authority of any adverse reactions arising from the use of the registered medicinal product immediately after he receives notice of such adverse reactions.
Authority
“Authority” means the Brunei Darussalam Medicines Control Authority established under section 5;
Authority
“Authority” means the Brunei Darussalam Medicines Control Authority established under section 5;
licensed importer
“licensed importer” means a person to whom an import licence has been issued under this Act;
licensed manufacturer
“licensed manufacturer” means a person to whom a manufacturer’s licence has been issued under this Act, and includes a contract manufacturer;
licensed wholesaler
“licensed wholesaler” means a person to whom a wholesaler’s licence has been issued under this Act;
product licence
“product licence” has the meaning ascribed to it by sections 11 and 15, and includes any provisional licence under section 17;
registered medicinal product
“registered medicinal product” means a product registered in accordance with the provisions of this Act;